Trial Profile
Open-label study to evaluate efficacy and safety of Cystadane for the treatment of aspartylglucosaminuria Cystadane aspartyyliglukosaminurian hoidossa: tehoa ja turvallisuutta koskeva tutkimus
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Oct 2017
Price :
$35
*
At a glance
- Drugs Betaine (Primary)
- Indications Aspartylglucosaminuria
- Focus Therapeutic Use
- 04 Oct 2017 New trial record